PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.51%
Positive revenue growth while CSIQ is negative. John Neff might see a notable competitive edge here.
24.75%
Positive gross profit growth while CSIQ is negative. John Neff would see a clear operational edge over the competitor.
89.86%
Positive EBIT growth while CSIQ is negative. John Neff might see a substantial edge in operational management.
93.76%
Positive operating income growth while CSIQ is negative. John Neff might view this as a competitive edge in operations.
191.18%
Positive net income growth while CSIQ is negative. John Neff might see a big relative performance advantage.
194.44%
Positive EPS growth while CSIQ is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
180.00%
Positive diluted EPS growth while CSIQ is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.60%
Share reduction more than 1.5x CSIQ's 4.25%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
6.01%
Diluted share count expanding well above CSIQ's 3.49%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
53.52%
Positive OCF growth while CSIQ is negative. John Neff would see this as a clear operational advantage vs. the competitor.
351.94%
Positive FCF growth while CSIQ is negative. John Neff would see a strong competitive edge in net cash generation.
78.80%
10Y revenue/share CAGR under 50% of CSIQ's 9877.79%. Michael Burry would suspect a lasting competitive disadvantage.
121.98%
5Y revenue/share CAGR under 50% of CSIQ's 540.54%. Michael Burry would suspect a significant competitive gap or product weakness.
21.07%
Positive 3Y CAGR while CSIQ is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
108.12%
OCF/share CAGR of 108.12% while CSIQ is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
165.11%
OCF/share CAGR of 165.11% while CSIQ is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
122.81%
3Y OCF/share CAGR of 122.81% while CSIQ is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
125.74%
Below 50% of CSIQ's 438.16%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
552.49%
5Y net income/share CAGR above 1.5x CSIQ's 153.72%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
2520.61%
Positive short-term CAGR while CSIQ is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
-29.92%
Negative 5Y equity/share growth while CSIQ is at 2.27%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-44.44%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-46.16%
Firm’s AR is declining while CSIQ shows 21.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-4.56%
Inventory is declining while CSIQ stands at 62.84%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.86%
Negative asset growth while CSIQ invests at 13.96%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.55%
Under 50% of CSIQ's 20.84%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
0.36%
Debt shrinking faster vs. CSIQ's 19.89%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-1.33%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-2.89%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.